Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?
Journal of cancer research and therapeutics（2023）
摘要
In mRCC patients, the RDW value measured before first-line VEGFR TKI therapy is an independent prognostic marker.
更多查看译文
关键词
renal cell carcinoma,vascular endothelial growth factor,endothelial growth factor,first-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要